While advancements have shed light on how CAFs influence TECs behavior, contributing to abnormal tumor vasculature and therapeutic resistance, there remains a significant gap in understanding how TECs reciprocally affect CAFs emergence and behavior. This evidence concerns the gene TBX1 and neoplasm.